Hematologic Malignancies Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Hematologic Malignancies stocks.

Hematologic Malignancies Stocks Recent News

Date Stock Title
Nov 2 INCY What Moved Markets This Week
Nov 1 KYMR Kymera Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Nov 1 KYMR Kymera Q3 Loss Narrower Than Expected, Pipeline in Focus
Nov 1 KYMR Kymera Therapeutics Inc (KYMR) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...
Nov 1 KYMR U.S. Drugmakers Are Breaking Up With Their Chinese Supply-Chain Partners
Oct 31 KYMR Kymera Therapeutics, Inc. (KYMR) Reports Q3 Loss, Lags Revenue Estimates
Oct 31 HOWL Werewolf Therapeutics Announces Promising New Development Candidate, WTX-921, a first-of-its-kind IL-10 INDUKINEā„¢ Molecule for Inflammatory Diseases
Oct 31 INCY Incyte: Q3 Earnings Ramping Up Growth To Jump The Patent Cliff
Oct 31 KYMR Kymera Therapeutics GAAP EPS of -$0.82 beats by $0.02, revenue of $3.74M misses by $6.6M
Oct 31 KYMR Kymera Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update
Oct 31 CRBU Is Caribou Biosciences (CRBU) a Promising Gene Editing Stock?
Oct 30 INCY Incyte's Jakafi Demand Is Strong, Analyst Upgrades Stock
Oct 30 INCY Incyte Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Oct 30 PRTC PureTech to Present at Two Upcoming Investor Conferences
Oct 30 INCY Incyte Corp (INCY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Oct 30 INCY Q3 2024 Incyte Corp Earnings Call
Oct 29 INCY S&P 500 Gains and Losses Today: Ford Stock Falters as Earnings Miss the Mark
Oct 29 INCY Incyte Breaks Out To 17-Month High As Jakafi Demand Surges
Oct 29 INCY Incyte Corporation (INCY) Q3 2024 Earnings Call Transcript
Oct 29 INCY Incyte Rallies on Strong Q3 Revenue, Jakafi Outlook Lifted
Hematologic Malignancies

Hematologic malignancies are cancers of the blood, bone marrow, and lymphatic system. These cancers can affect the production and function of blood cells, leading to a variety of symptoms and complications. Common types of hematologic malignancies include leukemia, lymphoma, and multiple myeloma. Treatment for hematologic malignancies may include chemotherapy, radiation therapy, stem cell transplant, and targeted therapy.

Browse All Tags